clinical trial · NCT06527872
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Lupus NephritisNone (Observational study)
brief summary
The purpose of the OBSErve-LN study is to assess the real-world use and effectiveness of belimumab in routine practice for the treatment of adults with active LN in multiple countries of interest. This study aims to provide the first long-term (up to 5 years) assessment of renal function preservation in belimumab treated participants.
started
Oct 4, 2024
primary completion
Mar 29, 2029
completion
Mar 29, 2029
last updated
Jul 2, 2026
detailed description
This is a Phase 4 study and will involve both prospective and retrospective data collection from participants.
official title
The Evaluation Of Use of Belimumab in Routine Care SEttings in Lupus Nephritis (LN): the OBSErve-LN Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol